Skip to main content
logo
Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.910
-0.030 (-1.55%)
At close: Jul 31, 2026, 4:00 PM EDT
1.930
+0.020 (1.05%)
Pre-market: Aug 3, 2026, 4:10 AM EDT

Compass Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.85---
Revenue Growth
------
Gross Profit
--0.85---
Operating Income
-75.17-145.68-114.1-50.36-41.66-81.88
Net Income
-68.17-66.49-49.38-42.49-39.23-82.18
Earnings Per Share
-0.41-0.42-0.36-0.33-0.37-1.31
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
194.69208.91126.72152.46186.61144.51
Total Debt
9.799.836.631.732.944.04
Net Cash (Debt)
184.9199.08120.09150.73183.67140.48
Net Cash Growth
74.01%65.78%-20.33%-17.94%30.75%272.20%
Net Cash Per Share
1.091.260.871.191.752.23

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-53.2-49.14-44.86-40.62-34.13-19.67
Capital Expenditures
-0.09-0.03-0.04-0.03-0.21-1.57
Free Cash Flow
-53.29-49.17-44.9-40.65-34.34-21.23
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--100.00%---
Operating Margin
---13423.50%---
Pretax Margin
---11717.65%---
Profit Margin
---5808.82%---
FCF Margin
---5282.24%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--235.11---